Biontech

An der Goldgrube 12
55131 Mainz


Contact WebSite

Article

BioNTech to Receive $145 Million to Expand mRNA Vaccine Production in Africa
06.06.2024 • News

BioNTech to Receive $145 Million to Expand mRNA Vaccine Production in Africa

German biotech company BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) are expanding their strategic partnership to contribute to building a sustainable and resilient end-to-end African vaccine ecosystem. The partners said that CEPI will commit up to $145 million to support BioNTech to establish mRNA vaccine R&D as well as clinical and commercial-scale manufacturing capabilities at the company’s facility in Kigali, Rwanda.

BioNTech Raises $250 Million for Vaccine Race
01.07.2020 • News

BioNTech Raises $250 Million for Vaccine Race

German biotech BioNTech, which is working on developing an mRNA vaccine against Covid-19 and has aligned itself with US pharma major Pfizer, this week raised $250 million (€223 million) in an offering that attracted Singapore state-owned private equity investor Temasek and other unnamed accredited investors.